|
|
- Dr. Kenneth Eilertsen (PhD), President and cofounder, has over 20 years of cell reprogramming experience and invented NuPotential's internationally recognized core cell reprogramming technologies. His industrial experience includes a senior research role at Johnson and Johnson as well as his tenure as Vice President of Research at Infigen, Inc. (DeForest, WI) where in addition to leading the company contract research operations (Genmark) he and his team cloned the second mammal by nuclear transfer. Dr. Eilertsen holds a faculty appointment as Assistant Professor of Epigenetics and Nuclear Reprogramming at the world renowned Pennington Biomedical Research Center (Baton Rouge, LA).
|
- Joan Neuscheler (MBA), Director and consultant, has over 25 years of healthcare venture investing, fundraising, financial, and operations management experience.
|
- Dr. Jong Rim (DVM, PhD), Senior Scientist, trained at the prestigious Johns Hopkins University and has over 15 years of research experience in obesity and type II diabetes.
|
- Dr. Jarek Staszkiewicz (DVM, PhD), Senior Scientist, is a Fulbright Scholar with over 15 years of research experience in stem cells and regenerative medicine.
|
- Christian Barnes (MPA), Molecular Biology Lab Manager, trained under Nobel Laureate Hamilton O. Smith at the prestigious J. Craig Venter Institute.
|
- Lettie Harkins, Cell Culture Manager, serves as NuPotential's Business Manager.
|
Phone:225/615-8955
Fax:225/615-8954
|
|
